Terms: = Lung cancer AND PCM1, Q15154, PTC4, ENSG00000078674, 5108 AND Treatment
3 results:
1. Anticancer activity of the Aurora A kinase inhibitor MK-5108 in non-small-cell lung cancer (NSCLC) in vitro as monotherapy and in combination with chemotherapies.
Chinn DC; Holland WS; Mack PC
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1137-49. PubMed ID: 24756365
[TBL] [Abstract] [Full Text] [Related]
2. Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Choeyprasert W; Natesirinilkul R; Charoenkwan P; Sittipreechacharn S
Asian Pac J Cancer Prev; 2013; 14(2):1101-6. PubMed ID: 23621194
[TBL] [Abstract] [Full Text] [Related]
3. Phase II study of cisplatin continuous infusion plus vindesine in the treatment of non-small-cell lung cancer.
Mori K; Saito Y; Tominaga K
Am J Clin Oncol; 1992 Aug; 15(4):344-7. PubMed ID: 1325109
[TBL] [Abstract] [Full Text] [Related]
